GE HealthCare outlines big plans for AI-enabled devices
GE HealthCare has bold plans to increase revenues by adding more than 100 AI-enabled devices in the next three years.
Related Articles
Revolutionize intensive care through AI
The ability to leverage real-time data would be a powerful tool in helping clinicians decide the next steps for ICU patients.
Tuesday, November 26, 2024 – KFF Health News
Weight loss drug coverage, the MAHA movement, Medicaid, Medicare, trans health, medical debt, miscarriage care, and more.
Eiffel-by-Night Sign | NEJM
A 50-year-old man presented with a 1-year history of progressive headaches. On examination, there was neck stiffness and dysmetria in both arms. An MRI of…
MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding – MedCity News
In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the…
How space became a place for the study of aging
Stanford Medicine scientists are studying why even brief trips into space can weaken muscle and heart tissue, mimicking decades of aging on Earth.
THCB Gang Episode 146, Tuesday November 26 – The Health Care Blog
Joining Matthew Holt (@boltyboy) on #THCBGang on Tuesday November 26 at 1PM PT 4PM ET are THCB regular writer and ponderer of odd juxtapositions Kim…
What’s the Nocebo Effect?
You’ve probably heard of the placebo effect. But there’s another side to that coin. It’s the nocebo effect. And it can harm your well-being. Here’s…
Intel’s CHIPS Act funding cut by over $600 million
The White House has cut Intel’s CHIPS Act award by over $600 million. Initially set to receive $8.5 billion, the company will now get up…
Climate Change, Floods, and Human Health | NEJM
With climate change, exposure to floods has increased and is linked to adverse health outcomes, such as injuries, diseases, and mental health harms, all of…
Biden proposes expanded Medicare, Medicaid coverage of obesity drugs
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk’s Wegovy, for more than 7 million people with Medicare and…
